OIC-A006 promotes osteogenesis in vitro and in vivo

Pharmazie

Volumn 63, Issue 10, 2008, Pages 751-756

  Cai, Ming ^a   Liu, Xiaodong ^a   Shao, Jin ^a   Qi, Jin ^a   Wang, Jun ^a   Zhu, Yaping ^a   Zhou, Qi ^a   Wang, Jinshen ^a   Zhao, Qiang ^a   Li, Guosong ^a   Liang, Jing ^a   Lu, W W ^b   Deng, Lianfu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINE; OIC A006; OSTEOCALCIN; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SYNTHESIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MICROCAPSULE; MOUSE; NONHUMAN; RABBIT; SKULL DEFECT; SUSTAINED DRUG RELEASE;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; METATARSAL BONES; MICE; MICE, INBRED C57BL; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; PREGNANCY; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKULL; STROMAL CELLS;

EID: 54149114730     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8559     Document Type: Article

References (19)

1. Aubin JE, Bellows CG, Turksen K, Liu F, Heersche JNM (1992) Analysis of the osteoblast lineage and regulation of differentiation. In: Slavkin H, Proce P (eds) Chemistry and Biology of Mineralized Tissues Elsevier Science Publishers, New York, pp 267-376.
2. Aubin JE, Turksen K, Heersche JNM (1993) Osteoblastic cell lineage. In: Noda M (ed) The Cellular and Molecular Biology of the Bone, Academic Press, New York, pp 1-45.
3. Bellows CG, Aubin JE, Heersche JN, Antosz ME (1986) Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcit Tissue Int 38: 143-154.
4. Bolander ME (1992) Regulation of fracture repair by growth factors. Proc Soc Exp Biol Med 200: 165-170.
5. Bourque WT, Gross M, Hall BK (1993) Expression of four growth factors during fracture repair. Int J Dev Biol 37: 573-579.
6. Fukuda S (2005) Chelating agents used for plutonium and uranium removal in radiation emergency Medicine. Curr Med Chem 12: 2765-2770.
7. Hanada K, Dennis JE, Caplan AI (1997) Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12: 1606-1614.
8. Heckman JD, Ehler W, Brooks BP, Aufdemorte TB, Lohmann CH, Morgan T, Boyan BD (1999) Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. J Bone Joint Surg Am 81: 1717-1729.
9. Henry C, Rakba N, Imbert D, Thomas F, Baret P, Serratrice G, Gaude D, Pierre JL, Ward RJ, Crichton RR, Lescoat G (2001) New 8-hydroxyquinoline and catecholate iron chelators: influence of their Partition coefficient on the their biological activity. Biochem Pharmacol. 15, 62 (10): 1355-1362.
10. Hughes FJ, McCulloch CAG (1991) Stimulation of the differentiation of osteogenic rat bone marrow cells by osteoblast cultures. Lab Invest 64: 617-622.
11. Lind M (1996) Growth factors: Possible new clinical tools. Acta Orthop Scand 67: 407-417.
12. Maniatopoulos C, Sodek J, Melcher AH (1988) Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254: 317-330.
13. Mundy G, Garrett R, Harris S et al. (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286: 1946-1949.
14. Nash TJ, Howlett CR, Martin C, Steele J, Johnson KA, Hicklin DJ (1994) Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15: 203-208.
15. Notoya K, Nagai H, Oda T, Gotoh M, Hoshino T, Muranishi H, Taketomi S, Sohda T, Makino H (1999) Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778. J Pharmacol Exp Ther 290: 1054-1064.
16. Notoya K, Yoshida K, Tsukuda R, Taketomi S (1994) Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture. J Bone Miner Res 9: 395-400.
17. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, Dijke PT, Sakou T (1998) Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22: 605-612.
18. Riley A, Lane JM, Urist MR, Lyons KM, Liebermann IR (1996) Bone morphogenetic protein-2: biology and application. Clinic Orthop 324: 324-346.
19. Simmons DJ (1985) Fracture healing perspectives. Clin Orthop Relat Res 200: 100-113.